Ypsomed Holding AG
Ypsomed Holding AG (YPSN) is a leading Swiss company specializing in the development and manufacturing of injection and infusion systems for self-medication. The company operates primarily in the healthcare sector, focusing on innovative delivery systems for biologics and other pharmaceuticals. Ypsomed's core products include pen systems for insulin and other medications, as well as wearable infusion systems and other medical devices aimed at enhancing patient care and improving treatment adherence.